CHRONIC RENAL INSUFFICIENCY
Clinical trials for CHRONIC RENAL INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RENAL INSUFFICIENCY trials appear
Sign up with your email to follow new studies for CHRONIC RENAL INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HIV patients get kidney transplants: rejection rates tracked
Disease control CompletedThis study followed 27 people with HIV who had end-stage kidney disease and received a kidney transplant. Researchers wanted to see how many patients would have graft rejection within 6 months while taking a three-drug HIV regimen that included raltegravir. The goal was to better…
Matched conditions: CHRONIC RENAL INSUFFICIENCY
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 17, 2026 16:52 UTC
-
New drug aims to tame inflammation in kidney disease patients
Disease control CompletedThis study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a blood marker for inflammation (hs-CRP). The goal was to see if monthly or quarterly injections could safely lower inflammation, which is linked to worse kidney outcomes. The stu…
Matched conditions: CHRONIC RENAL INSUFFICIENCY
Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Kidney function may change how drug works: new study
Knowledge-focused CompletedThis study looked at how the drug stiripentol is processed in people with mild, moderate, or severe kidney disease compared to those with normal kidneys. 39 adults took the drug by mouth, and researchers measured drug levels in the blood to see if dose adjustments are needed. The…
Matched conditions: CHRONIC RENAL INSUFFICIENCY
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated May 17, 2026 16:49 UTC
-
Kidney patients on dialysis: new study checks blood thinner safety
Knowledge-focused CompletedThis study looked at how a single dose of the blood thinner apixaban is processed in the body of people with end-stage kidney disease who are on peritoneal dialysis, compared to people with normal kidney function. Researchers measured drug levels in the blood and urine over time.…
Matched conditions: CHRONIC RENAL INSUFFICIENCY
Phase: PHASE1 • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC